Rob Bennett, CEO of Rehab, discusses the current use of chatbots and voice technology in healthcare systems and where current opportunities are being missed.
Here, we discover why Gendius’ remote management technology, Intellin®, is poised to transform the way that we manage long-term health conditions including diabetes.
Peter Walker, CTO EMEA at Blue Prism, discusses how intelligent automation is being used by the NHS to streamline operations and improve patient outcomes, particularly in light of the COVID-19 crisis.
Alex Evans, UK Country Manager for ViCentra B.V., discusses how insulin pump system Kaleido can provide solutions to reduce the practical and emotional burden of living with diabetes.
COVID-19 has provided an all-too-real use case for video consultations in the NHS, but it’s the power it gives patients over their own care, that will ensure it survives long after the pandemic, says Rowan Pritchard Jones.
Finmark Sauna explores the health benefits associated with cardiovascular disease, mental health, pain and respiratory disease, of Finnish sauna bathing.
Dr Deborah Lee, Dr Fox Online Pharmacy, explores how aromatherapy is fast emerging as a form of alternative medicine for many health conditions, including insomnia.
Justin Hall, GM and VP EMEA, iRhythm Technologies, explores the impact that COVID-19 has had on the rapid scaling of new technology-enabled healthcare services.
Lord Victor Adebowale, chair and co-founder of Visionable, discusses why getting technology design right could be key to avoiding health inequity, especially during the COVID-19 crisis.
Researchers from the University of North Carolina and NC State have developed artificial beta cells that automatically release insulin into the bloodstream when glucose levels rise, leading the way for new diabetes treatment.
